MLB notebook: Padres' Maybin suspended 25 games
Padres outfielder Cameron Maybin was suspended 25 games by Major League Baseball on Wednesday for testing positive for an amphetamine.
Maybin said in a statement distributed through the Major League Baseball Players Association the failed test was the result of a change in the medication he was using to treat Attention Deficit Disorder.
Under the drug agreement between MLB and its players' union, 25 games is the penalty for a second positive amphetamine test. A first positive results in six unannounced follow-up tests over the next year.
Rangers trade Soria to Tigers
The Rangers traded reliever Joakim Soria to the Tigers for right-handed pitchers Jake Thompson and Corey Knebel.
Thompson (No. 3) and Knebel (No. 5) are two of the top five prospects in the Tigers organization. Thompson is at Double-A, and Knebel is in Triple-A.
Astros lose Springer
The Astros placed outfielder George Springer on the 15-day disabled list with a strained left quadriceps and recalled utility man Marc Krauss from Triple-A Oklahoma City.
Springer's stint on the DL is retroactive to Sunday.
Nats place Zimmerman on DL
A day after leaving Tuesday's game against the Rockies while running out a grounder, Ryan Zimmerman was placed on the 15-day disabled list with a strained right hamstring.
To take his place on the roster, the Nationals recalled infielder Zach Walters from Triple-A Syracuse.
Yankees' INF Johnson hurt
Yankees infielder Kelly Johnson was placed on the 15-day disabled list with a strained left groin. Johnson was injured trying to beat out a 10th-inning grounder Tuesday.
New York selected the contract of right-hander Chris Leroux from Triple-A Scranton/Wilkes-Barre.
Red Sox rookie Holt finally sits
Versatile Red Sox rookie Brock Holt wasn't in the starting lineup for the first time since being recalled May 17, ending a streak of 59 straight games.
Red Sox manager John Farrell said Holt will be in the lineup Thursday.
Show commenting policy
TribLive commenting policy
Subscribe today! Click here for our subscription offers.